LifeMD Reports Mixed Q1 Results: Revenue Beats Guidance Amid Wider Net Loss and Strong Subscriber Growth
LFMD sits 79% above its 52-week low of $2.56.
Summary
LifeMD reported Q1 2026 revenue of $50.2 million, exceeding guidance, driven by record subscriber growth in key segments, but also posted a significantly wider net loss and an adjusted EBITDA loss.
Key Events · Earnings and Guidance · LFMD
-
Q1 Revenue Exceeds Guidance
LifeMD reported Q1 2026 revenue of $50.2 million, surpassing its guidance range of $48-$49 million, despite a slight year-over-year decrease.
-
Significant Operational Growth
The company achieved record 42,000 net telehealth subscriber additions, ending the quarter with over 365,000 active subscribers (+26% YoY). GLP-1 patient sign-ups grew 120% QoQ, and Women's Health sign-ups surged 657% QoQ.
-
Wider Net Loss and Adjusted EBITDA Loss
GAAP net loss from continuing operations widened significantly to $9.6 million ($0.20/share) from $0.96 million ($0.06/share) in the prior-year period. Adjusted EBITDA shifted to a $4.5 million loss from a $3.7 million gain YoY.
-
Gross Margin Expansion & Strong Liquidity
Gross margin expanded to 88% from 84% YoY, reflecting favorable revenue mix. The company exited the quarter with $34.5 million in cash, no debt, and an undrawn $30 million revolving credit facility.
Analysis · LFMD · Industrial Applications And Services
This 8-K furnishes LifeMD's Q1 2026 earnings press release and an investor presentation. The results present a mixed financial picture, with strong operational growth and revenue exceeding guidance, but also a significantly wider GAAP net loss and a shift to an adjusted EBITDA loss compared to the prior year. The company demonstrated robust subscriber acquisition, particularly in GLP-1 and Women's Health segments, and improved gross margins. However, increased selling and marketing expenses contributed to the profitability decline. The affirmation of full-year guidance suggests management's confidence in a second-half recovery. This filing provides detailed context to the Q1 performance, which is crucial for investors to weigh against the concurrent 10-Q filing that disclosed a breach of a debt covenant, a more severe financial concern not addressed in this 8-K's press release.
At the time of this filing, LFMD was trading at $4.57 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $252.8M. The 52-week trading range was $2.56 to $15.84. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.